Menin Inhibitors 101 with Dr. Joshua Zeidner

Mary Arnett

Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.

Dr. Joshua Zeidner

Dr. Zeidner specializes in the management of patients with acute leukemia, MDS, and MPNs. His research focuses on developing innovative methods to improve clinical outcomes in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Dr. Zeidner is the Chief of the Leukemia Research Program at the University of North Carolina.